BSPM [Biostar Pharmaceuticals,] 8-K: (Original Filing)

[BIOSTAR PHARMACEUTICALS, RECEIVES NEWVERTISING APPROVAL FROM SHAANXI SFDA FOR MARKETING XIN AOXINGPSULE XIANYANG, China, April 27, 2010 (Xinhua-PRNewswire-FirstCall) On April 22, 2010 the Shaanxi SFDA published on its website a notification stating that the marketing language used innnection with several pharmaceutical products sold in the province are not within approved parameters.Biostar Pharmaceuticals flagship Hepatitis B]

By | 2016-02-07T17:30:24+00:00 April 28th, 2010|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: BIOSTAR PHARMACEUTICALS, RECEIVES NEWVERTISING APPROVAL FROM SHAANXI SFDA

[BIOSTAR PHARMACEUTICALS, RECEIVES NEWVERTISING APPROVAL FROM SHAANXI SFDA FOR MARKETING XIN AOXINGPSULE XIANYANG, China, April 27, 2010 (Xinhua-PRNewswire-FirstCall) On April 22, 2010 the Shaanxi SFDA published on its website a notification stating that the marketing language used innnection with several pharmaceutical products sold in the province are not within approved parameters.Biostar Pharmaceuticals flagship Hepatitis B]

By | 2016-02-07T17:31:04+00:00 April 28th, 2010|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments

CJJD [CHINA JO-JO DRUGSTORES] 8-K: (Original Filing)

[China Jo-Jo Drugstores, Inc. Announces Closing of Public Offering of Common Stock HANGZHOU, China--(BUSINESS WIRE)--April 28, 2010--China Jo-Jo Drugstores, Inc. (NASDAQ:CJJDD) ("Jo-Jo Drugstores" or the "Company"), which operates a retail pharmacy chain in the People’s Republic of China (the “PRC”), today announced that it closed its previously announced public offering of 3.5 million shares of common stock. Gross proceeds to]

Skip to toolbar